Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Miss Dorsaf Mlayeh

Hopital Robert Ballanger, Aulnay sous Bois (France)

10 More presentations in this session

Presentation thumbnail

Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.

Professor K. Neven (Essen, DE)

Abstract Slides

Presentation thumbnail

Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)

Doctor R. Tieleman (Groningen, NL)

Abstract Slides

Presentation thumbnail

Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation

Doctor S. Chen (Greifswald, DE)

Presentation thumbnail

Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Professor J. Mansourati (Brest, FR)

Presentation thumbnail

Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.

Doctor N. Wainstejn (Berlin, DE)

Access the full session

Session thumbnail

Poster session 1 - Atrial Fibrillation - Stroke Prevention

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on stroke prevention in atrial fibrillation

Congress Presentation

Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources